Veradermics, Inc. (MANE)

122.28 +13.46 (+12.37%) USD  |  NYSE  |  Oct 19, 16:00
124.00 +1.72 (+1.41%) Pre-Market: 20:00
More

Veradermics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for MANE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Return on Net Operating Assets Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --
Date Value
March 31, 2026 --

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade
Johnson & Johnson Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade